CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
58 hedge funds and large institutions have $215M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2016 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
2,651% more capital invested
Capital invested by funds: $7.81M → $215M (+$207M)
617% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 6
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
176% more funds holding
Funds holding: 21 → 58 (+37)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
95% less call options, than puts
Call options by funds: $39K | Put options by funds: $788K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$4.75M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
+$4.64M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$4.64M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.46M |
| 5 |
PA
Perceptive Advisors
New York
|
+$3.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.02M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$180K |
| 3 |
NC
Nexthera Capital
New York
|
-$158K |
| 4 |
HF
Hoxton Financial
Shepherdstown,
West Virginia
|
-$84K |
| 5 |
FWM
Frontier Wealth Management
Kansas City,
Missouri
|
-$71K |
CPXX Hedge Fund Activity: Q1 2016 in Review
58 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q1 2016, worth a combined $215M — up 2,651% from $7.81M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CPXX positions and 6 closed out — a net gain of 37 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $4.75M. The largest seller was Sabby Management, cutting an estimated $1.02M.
- 58 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q1 2016, up from 21 in Q4 2015.
- Funds reported $215M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q1 2016, up 2,651% quarter-over-quarter.
- 43 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q1 2016 and 6 closed out, a net change of +37 holders.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q1 2016 was Visium Asset Management, an estimated $4.75M added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q1 2016 was Sabby Management, an estimated $1.02M sold.
Based on aggregated 13F filings for Q1 2016.